Neola Medical AB (NEOLA) — Cash Flow-to-Debt Ratio
Neola Medical AB (NEOLA) has a Cash Flow-to-Debt Ratio of -1.26x as of December 2025, meaning its operating cash flow of Skr-3.77 Million could theoretically repay -1% of its total liabilities (Skr3.00 Million) in one year. See NEOLA free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Neola Medical AB Cash Flow-to-Debt Ratio (2018–2025)
Historical debt coverage capacity for Neola Medical AB across 8 annual periods. Also explore NEOLA net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Neola Medical AB (2018–2025)
Year-by-year debt coverage analysis for Neola Medical AB. For market capitalisation and broader financial context, see NEOLA market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.99x | Skr-11.95 Million | Skr3.00 Million | ▼ -71.0% |
| 2024 | -2.33x | Skr-10.84 Million | Skr4.65 Million | ▼ -149.1% |
| 2023 | -0.94x | Skr-6.54 Million | Skr6.99 Million | ▲ +13.6% |
| 2022 | -1.08x | Skr-8.50 Million | Skr7.84 Million | ▲ +50.1% |
| 2021 | -2.17x | Skr-6.93 Million | Skr3.19 Million | ▲ +13.6% |
| 2020 | -2.51x | Skr-6.08 Million | Skr2.42 Million | ▼ -82.4% |
| 2019 | -1.38x | Skr-2.07 Million | Skr1.50 Million | ▲ +30.0% |
| 2018 | -1.97x | Skr-1.32 Million | Skr671.00K | — |